Edition:
United Kingdom

Beigene Ltd (BGNE.OQ)

BGNE.OQ on NASDAQ Stock Exchange Global Select Market

134.35USD
20 Mar 2019
Change (% chg)

$-2.21 (-1.62%)
Prev Close
$136.56
Open
$136.95
Day's High
$138.30
Day's Low
$134.32
Volume
50,184
Avg. Vol
191,205
52-wk High
$220.09
52-wk Low
$105.19

Chart for

About

BeiGene, Ltd. is principally engaged in biopharmaceutical business. The Company is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company's main products include Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317) and... (more)

Overall

Beta: --
Market Cap(Mil.): $4,400.80
Shares Outstanding(Mil.): 3.26
Dividend: --
Yield (%): --

Financials

  BGNE.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -4.93 -- --
ROI: -57.59 8.89 13.82
ROE: -77.45 10.00 15.25

Earnings vs. Estimates